8-K: Neuronetics Amends Madryn Registration Rights, Secures Voting Pact

Neuronetics and Madryn Asset Management LP have amended their Registration Rights Agreement, streamlining future share resales and securing Madryn's voting support for key proposals at the 2026 annual meeting.

Summary

• Neuronetics, Inc. and Madryn Asset Management LP (and its affiliates) executed a Second Amendment to their Registration Rights Agreement on March 2, 2026.
• The amendment stipulates that if Neuronetics receives a Shelf Notice from Madryn after the effective date of the Second Amendment, Neuronetics will file a Registration Statement for the resale of Madryn's beneficially owned shares within five business days after filing its Annual Report on Form 10-K for the year ended December 31, 2025.
• Madryn Parties agree to vote all their Neuronetics shares at the 2026 annual meeting in accordance with the Board of Directors' recommendations on specific proposals, including the re-election of current directors, ratification of the independent registered public accounting firm for 2026, advisory approval of executive compensation, and approval of a new equity incentive plan (under certain conditions).
• Madryn Parties also agree not to submit any shareholder proposals pursuant to Rule 14a-8 of the Exchange Act or otherwise for a period of two years after the effective date of the original Arrangement Agreement.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a procedural amendment that provides Neuronetics with increased stability regarding shareholder voting and reduces potential activist shareholder proposals from Madryn for a defined period, while also clarifying Madryn's resale rights.

Positives

• Madryn Parties commit to voting their shares in line with Neuronetics' Board of Directors' recommendations at the 2026 annual meeting for key proposals, including director re-election and auditor ratification, which enhances corporate governance stability.
• Madryn Parties are restricted from submitting shareholder proposals for two years, potentially reducing activist pressure or distractions for management.
• The amendment clarifies the timeline for Neuronetics to file a resale registration statement for Madryn's shares, providing more certainty regarding future share liquidity for Madryn.

Negatives

• The amendment facilitates the potential future resale of a significant block of shares by Madryn Parties, which could introduce selling pressure on the stock if executed.

Risks

• Potential for increased supply of Neuronetics' common stock on the market if Madryn Parties elect to sell their registered shares, which could impact share price.
• The voting agreement, while beneficial for current management, centralizes voting power for certain proposals, potentially limiting other shareholder influence on those specific items.

Future Outlook

The filing outlines a future commitment for Neuronetics to file a resale registration statement for Madryn's shares within five business days after its 2025 10-K filing, contingent on receiving a Shelf Notice. It also secures Madryn's voting support for key management proposals at the 2026 annual meeting and restricts Madryn from submitting shareholder proposals for two years.

Industry Context

StockSavvy.ai notes that amendments to registration rights agreements and voting pacts with significant institutional investors are common mechanisms for companies to manage shareholder relations and provide clarity on future share liquidity. This type of agreement helps stabilize corporate governance by aligning a major shareholder's voting with the board's recommendations on critical matters, which can be viewed positively by the market as it reduces potential for shareholder activism on those specific issues.

Corporate Governance

Related Party Transactions

• The Second Amendment to the Registration Rights Agreement is between Neuronetics, Inc. and Madryn Asset Management LP and its affiliates, a significant investor in the company.

Stakeholder Impact

• Shareholders: Madryn's voting commitment provides stability for the Board's proposals, while the potential for future share resale by Madryn could impact market dynamics.
• Board of Directors: Gains increased certainty and support from a major investor for key governance proposals at the 2026 annual meeting.

Next Steps

• Neuronetics will file its Annual Report on Form 10-K for the year ended December 31, 2025.
• If a Shelf Notice is received from Madryn, Neuronetics will prepare and file a Registration Statement for the resale of Madryn's shares within five business days after filing its 2025 10-K.
• The 2026 annual meeting of Neuronetics will take place, where Madryn Parties will vote their shares in accordance with the Board's recommendations on specified proposals.

Key Dates

Keywords

Registration Rights Agreement, Madryn Asset Management, Neuronetics, 8-K filing, corporate governance, shareholder voting, equity incentive plan, shelf registration, SEC filing